Covered recipient · General Payments record
CARL BARTON GILLOMBARDO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$3,794.96
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $685.56 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $242.66 | 7 |
| BOSTON SCIENTIFIC CORPORATION | $158.67 | 5 |
| Abbott Laboratories | $147.83 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $60.56 | 1 |
| Medtronic, Inc. | $41.92 | 2 |
| Janssen Pharmaceuticals, Inc | $33.92 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $147.83 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125357277 | CMS |
| ABIOMED | $23.69 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258296 | CMS |
| ABIOMED | $24.36 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258314 | CMS |
| ABIOMED | $92.49 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258318 | CMS |
| ABIOMED | $20.55 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258356 | CMS |
| ABIOMED | $30.09 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258368 | CMS |
| ABIOMED | $21.84 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258370 | CMS |
| ABIOMED | $29.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258390 | CMS |
| Boston Scientific Corporation | $5.63 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092499156 | CMS |
| Boston Scientific Corporation | $3.87 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092499152 | CMS |
| Boston Scientific Corporation | $133.54 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092499160 | CMS |
| Boston Scientific Corporation | $11.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092499158 | CMS |
| Boston Scientific Corporation | $4.43 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092499154 | CMS |
| Janssen Pharmaceuticals, Inc | $17.91 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078127156 | CMS |
| Janssen Pharmaceuticals, Inc | $16.01 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078127483 | CMS |
| Medtronic, Inc. | $21.43 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119566538 | CMS |
| Medtronic, Inc. | $20.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119566540 | CMS |
| Novartis Pharmaceuticals Corporation | $60.56 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086960819 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.